Home > Documents in Process > Ageing populations: new challenges in longevity. > print

001     283106
005     20260102094407.0
024 7 _ |a 10.1186/s12889-025-25531-w
|2 doi
024 7 _ |a pmid:41469611
|2 pmid
024 7 _ |a pmc:PMC12755007
|2 pmc
037 _ _ |a DZNE-2026-00002
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Callaway, Julia
|b 0
245 _ _ |a Ageing populations: new challenges in longevity.
260 _ _ |a London
|c 2025
|b BioMed Central
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1767343258_32511
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a High-income countries experienced unprecedented gains in life expectancy throughout the twentieth century. However, recent evidence suggests that these gains have slowed, especially at older ages. This paper focuses on recent trends in life expectancy and health in ageing populations in high-income countries.We analysed mortality and health data from the Human Mortality Database and the Global Burden of Disease. Additionally, we reviewed recent literature to explore changes in life expectancy, health-adjusted life expectancy, physical and cognitive decline, and the impact of ageing on healthcare expenditure in countries with high life expectancies.Although life expectancy continues to rise in high-income countries, the pace of improvement has slowed, especially among the oldest-old. While health-adjusted life expectancy has generally increased, the proportion of life spent in good health varies across countries, with notable differences in trends in physical and cognitive disabilities. In terms of economic implications, these findings highlight the importance of age and proximity to death as determinants of healthcare expenditures.The deceleration in life expectancy gains, particularly among the oldest populations, raises important questions about future trends in longevity. As physical and cognitive health change in older ages healthcare systems will face new and diverse challenges. Understanding the role of ageing and time-to-death in shaping healthcare costs will be critical for anticipating future needs in high-income countries.
536 _ _ |a 354 - Disease Prevention and Healthy Aging (POF4-354)
|0 G:(DE-HGF)POF4-354
|c POF4-354
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a Cognitive health
|2 Other
650 _ 7 |a Health economics
|2 Other
650 _ 7 |a Health expectancies
|2 Other
650 _ 7 |a Mortality
|2 Other
650 _ 7 |a Physical health
|2 Other
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Life Expectancy: trends
|2 MeSH
650 _ 2 |a Aged
|2 MeSH
650 _ 2 |a Longevity
|2 MeSH
650 _ 2 |a Aged, 80 and over
|2 MeSH
650 _ 2 |a Aging
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Developed Countries: statistics & numerical data
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Health Expenditures: trends
|2 MeSH
650 _ 2 |a Middle Aged
|2 MeSH
650 _ 2 |a Mortality: trends
|2 MeSH
650 _ 2 |a Global Burden of Disease
|2 MeSH
650 _ 2 |a Global Health
|2 MeSH
700 1 _ |a Strozza, Cosmo
|b 1
700 1 _ |a Christensen, Kaare
|b 2
700 1 _ |a Doblhammer, Gabriele
|0 P:(DE-2719)2811246
|b 3
|u dzne
700 1 _ |a Rau, Roland
|b 4
700 1 _ |a Søgaard, Jes
|b 5
773 _ _ |a 10.1186/s12889-025-25531-w
|g Vol. 25, no. 1, p. 4395
|0 PERI:(DE-600)2041338-5
|n 1
|p 4395
|t BMC public health
|v 25
|y 2025
|x 1471-2458
856 4 _ |u https://pub.dzne.de/record/283106/files/DZNE-2026-00002.pdf
|y Restricted
856 4 _ |u https://pub.dzne.de/record/283106/files/DZNE-2026-00002.pdf?subformat=pdfa
|x pdfa
|y Restricted
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 3
|6 P:(DE-2719)2811246
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-354
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Disease Prevention and Healthy Aging
|x 0
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b BMC PUBLIC HEALTH : 2022
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2024-04-10T15:34:53Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2024-04-10T15:34:53Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Open peer review
|d 2024-04-10T15:34:53Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2025-01-07
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2025-01-07
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2025-01-07
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2025-01-07
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2025-01-07
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2025-01-07
920 1 _ |0 I:(DE-2719)1012002
|k AG Doblhammer
|l Demographic Studies
|x 0
980 _ _ |a journal
980 _ _ |a EDITORS
980 _ _ |a VDBINPRINT
980 _ _ |a I:(DE-2719)1012002
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21